(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.08%) $0.927
(0.30%) $10.87
(0.07%) $0.793
(-0.31%) $92.29
4 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 10.52%
Live Chart Being Loaded With Signals
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease...
Stats | |
---|---|
Today's Volume | 121 632 |
Average Volume | 801 298 |
Market Cap | 3.82M |
EPS | $-0.0300 ( 2023-11-14 ) |
Next earnings date | ( $0 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.220 |
ATR14 | $0.00200 (1.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-29 | Schechter Jonathan | Buy | 20 000 | Stock Option (Right to Buy) |
2023-03-29 | Singer William S. | Buy | 20 000 | Stock Option (Right to Buy) |
2023-03-29 | Bernstein Bruce | Buy | 20 000 | Stock Option (Right to Buy) |
2023-03-29 | Silverman Joshua | Buy | 20 000 | Stock Option (Right to Buy) |
2022-12-16 | Singer William S. | Sell | 27 000 | Common Stock, par value $0.0001 per share |
INSIDER POWER |
---|
75.03 |
Last 67 transactions |
Buy: 1 842 000 | Sell: 283 116 |
Volume Correlation
Synaptogenix, Inc. Correlation
10 Most Positive Correlations | |
---|---|
GOSS | 0.958 |
VORB | 0.946 |
BCAB | 0.946 |
THTX | 0.944 |
XFOR | 0.943 |
FATE | 0.942 |
NVTSW | 0.941 |
RIVN | 0.939 |
NCBS | 0.938 |
ISPO | 0.938 |
10 Most Negative Correlations | |
---|---|
NWLI | -0.967 |
AMYT | -0.967 |
EZGO | -0.959 |
RXDX | -0.956 |
TACO | -0.956 |
MLCO | -0.955 |
LUNA | -0.954 |
HZNP | -0.953 |
EXAS | -0.953 |
MLVF | -0.953 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Synaptogenix, Inc. Correlation - Currency/Commodity
Synaptogenix, Inc. Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-5 714.00 (0.00 %) |
EPS: | $-0.780 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 723.00 (0.00 %) |
EPS: | $0.0713 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 724.00 (0.00 %) |
EPS: | $-0.560 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-1 690.00 (0.00 %) |
EPS: | $-0.190 |
Financial Reports:
No articles found.
Synaptogenix, Inc.
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators